202 related articles for article (PubMed ID: 12707356)
1. Delta 12-prostaglandin J2, a plasma metabolite of prostaglandin D2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis.
Heinemann A; Schuligoi R; Sabroe I; Hartnell A; Peskar BA
J Immunol; 2003 May; 170(9):4752-8. PubMed ID: 12707356
[TBL] [Abstract][Full Text] [Related]
2. Indomethacin causes prostaglandin D(2)-like and eotaxin-like selective responses in eosinophils and basophils.
Stubbs VE; Schratl P; Hartnell A; Williams TJ; Peskar BA; Heinemann A; Sabroe I
J Biol Chem; 2002 Jul; 277(29):26012-20. PubMed ID: 11980903
[TBL] [Abstract][Full Text] [Related]
3. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.
Ueki S; Kato H; Kobayashi Y; Ito W; Adachi T; Nagase H; Ohta K; Kayaba H; Chihara J
Int Arch Allergy Immunol; 2007; 143 Suppl 1():15-22. PubMed ID: 17541271
[TBL] [Abstract][Full Text] [Related]
4. A novel antagonist of CRTH2 blocks eosinophil release from bone marrow, chemotaxis and respiratory burst.
Royer JF; Schratl P; Lorenz S; Kostenis E; Ulven T; Schuligoi R; Peskar BA; Heinemann A
Allergy; 2007 Dec; 62(12):1401-9. PubMed ID: 17714552
[TBL] [Abstract][Full Text] [Related]
5. 15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils.
Monneret G; Li H; Vasilescu J; Rokach J; Powell WS
J Immunol; 2002 Apr; 168(7):3563-9. PubMed ID: 11907120
[TBL] [Abstract][Full Text] [Related]
6. A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils.
Royer JF; Schratl P; Carrillo JJ; Jupp R; Barker J; Weyman-Jones C; Beri R; Sargent C; Schmidt JA; Lang-Loidolt D; Heinemann A
Eur J Clin Invest; 2008 Sep; 38(9):663-71. PubMed ID: 18837743
[TBL] [Abstract][Full Text] [Related]
7. 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils.
Böhm E; Sturm GJ; Weiglhofer I; Sandig H; Shichijo M; McNamee A; Pease JE; Kollroser M; Peskar BA; Heinemann A
J Biol Chem; 2004 Feb; 279(9):7663-70. PubMed ID: 14668348
[TBL] [Abstract][Full Text] [Related]
8. Hierarchy of eosinophil chemoattractants: role of p38 mitogen-activated protein kinase.
Schratl P; Sturm EM; Royer JF; Sturm GJ; Lippe IT; Peskar BA; Heinemann A
Eur J Immunol; 2006 Sep; 36(9):2401-9. PubMed ID: 16906532
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells.
Gosset P; Bureau F; Angeli V; Pichavant M; Faveeuw C; Tonnel AB; Trottein F
J Immunol; 2003 May; 170(10):4943-52. PubMed ID: 12734337
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of guinea pig chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2).
Liu F; Gonzalo JA; Manning S; O'Connell LE; Fedyk ER; Burke KE; Elder AM; Pulido JC; Cao W; Tayber O; Qiu Y; Ghosh S; Ocain TD; Hodge MR; Suzuki-Yagawa Y
Prostaglandins Other Lipid Mediat; 2005 May; 76(1-4):133-47. PubMed ID: 15967168
[TBL] [Abstract][Full Text] [Related]
11. A novel PGD(2) receptor expressed in eosinophils.
Powell WS
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):179-85. PubMed ID: 12895601
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism.
Ward C; Dransfield I; Murray J; Farrow SN; Haslett C; Rossi AG
J Immunol; 2002 Jun; 168(12):6232-43. PubMed ID: 12055237
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin inhibits eosinophil migration to prostaglandin D2 : therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis.
Kataoka N; Satoh T; Hirai A; Saeki K; Yokozeki H
Immunology; 2013 Sep; 140(1):78-86. PubMed ID: 23582181
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
[TBL] [Abstract][Full Text] [Related]
15. The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking.
Schratl P; Royer JF; Kostenis E; Ulven T; Sturm EM; Waldhoer M; Hoefler G; Schuligoi R; Lippe IT; Peskar BA; Heinemann A
J Immunol; 2007 Oct; 179(7):4792-9. PubMed ID: 17878378
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 inhibits eosinophil trafficking through E-prostanoid 2 receptors.
Sturm EM; Schratl P; Schuligoi R; Konya V; Sturm GJ; Lippe IT; Peskar BA; Heinemann A
J Immunol; 2008 Nov; 181(10):7273-83. PubMed ID: 18981149
[TBL] [Abstract][Full Text] [Related]
17. PGD2 metabolism in plasma: kinetics and relationship with bioactivity on DP1 and CRTH2 receptors.
Schuligoi R; Schmidt R; Geisslinger G; Kollroser M; Peskar BA; Heinemann A
Biochem Pharmacol; 2007 Jun; 74(1):107-17. PubMed ID: 17452035
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2.
Schuligoi R; Sedej M; Waldhoer M; Vukoja A; Sturm EM; Lippe IT; Peskar BA; Heinemann A
J Leukoc Biol; 2009 Jan; 85(1):136-45. PubMed ID: 18835884
[TBL] [Abstract][Full Text] [Related]
19. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
[TBL] [Abstract][Full Text] [Related]
20. Physiological levels of 15-deoxy-Delta12,14-prostaglandin J2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-gamma ligation.
Kobayashi Y; Ueki S; Mahemuti G; Chiba T; Oyamada H; Saito N; Kanda A; Kayaba H; Chihara J
J Immunol; 2005 Nov; 175(9):5744-50. PubMed ID: 16237065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
